Drägerwerk AG & Co. KGaA (pref) (DRW3) - Total Liabilities

Latest as of June 2025: €1.52 Billion EUR ≈ $1.78 Billion USD

Based on the latest financial reports, Drägerwerk AG & Co. KGaA (pref) (DRW3) has total liabilities worth €1.52 Billion EUR (≈ $1.78 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore DRW3 operating cash flow to assess how effectively this company generates cash.

Drägerwerk AG & Co. KGaA (pref) - Total Liabilities Trend (2013–2024)

This chart illustrates how Drägerwerk AG & Co. KGaA (pref)'s total liabilities have evolved over time, based on quarterly financial data. Check Drägerwerk AG & Co. KGaA (pref) (DRW3) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Drägerwerk AG & Co. KGaA (pref) Competitors by Total Liabilities

The table below lists competitors of Drägerwerk AG & Co. KGaA (pref) ranked by their total liabilities.

Company Country Total Liabilities
Hunan Tyen Machinery Co Ltd A
SHG:600698
China CN¥437.15 Million
Beyondsoft Corp
SHE:002649
China CN¥1.36 Billion
Shanghai Xinhua Media Co Ltd
SHG:600825
China CN¥1.42 Billion
Reysas Tasimacilik ve Lojistik Ticaret AS
IS:RYSAS
Turkey TL9.11 Billion
Zhejiang Oceanking Development Co Ltd
SHG:603213
China CN¥1.37 Billion
Xiamen 35Com Tech
SHE:300051
China CN¥2.01 Billion
Pantoro Gold Ltd
AU:PNR
Australia AU$183.49 Million
NCR Voyix Corporation
NYSE:VYX
USA $2.77 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down Drägerwerk AG & Co. KGaA (pref)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Drägerwerk AG & Co. KGaA (pref) stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.74 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.04 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.51 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Drägerwerk AG & Co. KGaA (pref)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Drägerwerk AG & Co. KGaA (pref) (2013–2024)

The table below shows the annual total liabilities of Drägerwerk AG & Co. KGaA (pref) from 2013 to 2024.

Year Total Liabilities Change
2024-12-31 €1.56 Billion
≈ $1.82 Billion
-7.64%
2023-12-31 €1.69 Billion
≈ $1.97 Billion
-5.70%
2022-12-31 €1.79 Billion
≈ $2.09 Billion
-6.81%
2021-12-31 €1.92 Billion
≈ $2.24 Billion
-15.60%
2020-12-31 €2.27 Billion
≈ $2.66 Billion
+52.03%
2019-12-31 €1.49 Billion
≈ $1.75 Billion
+12.41%
2018-12-31 €1.33 Billion
≈ $1.55 Billion
+3.39%
2017-12-31 €1.29 Billion
≈ $1.50 Billion
-1.74%
2016-12-31 €1.31 Billion
≈ $1.53 Billion
-4.15%
2015-12-31 €1.37 Billion
≈ $1.60 Billion
+2.09%
2014-12-31 €1.34 Billion
≈ $1.56 Billion
+7.08%
2013-12-31 €1.25 Billion
≈ $1.46 Billion
--

About Drägerwerk AG & Co. KGaA (pref)

F:DRW3 Germany Medical Devices
Market Cap
$895.84 Million
€766.26 Million EUR
Market Cap Rank
#9608 Global
#1166 in Germany
Share Price
€89.10
Change (1 day)
+0.34%
52-Week Range
€60.20 - €98.90
All Time High
€99.80
About

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas m… Read more